However, the cellular pathogenic cascade underlying how GLA deficiency results in progressive clinical symptoms remains unclear; moreover, the associated pathogenic cascade has already been initiated before the onset of the organ symptoms of Fabry disease, making de novo diagnosis difficult (Jabbarzadeh-Tabrizi et al., 2020; Spinelli et al., 2020). This evidence concerns the gene GLA and Fabry disease.